CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- 4 Planned sale Chief Regulatory Officer sold 10,000 shares at $50.08 ($500,767)
- 4 Open-market buy Director bought 5,882 shares at $42.50 ($249,985)
- 4 Planned sale Chief Regulatory Officer sold 10,000 shares at $45.31 ($453,053)
- 4 Planned sale Chief Regulatory Officer sold 10,000 shares at $40.00 ($400,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Legal Officer sold 3,864 shares at $27.82 ($107,498)
- 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 15,000 shares at $29.06 ($435,875)
- 4 Open-market buy Director bought 250,000 shares at an average $21.11 ($5,277,311)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale PRESIDENT AND CEO sold 19,688 shares at an average $27.78 ($546,914)
- 4 Grant or award SVP, FINANCE, CHIEF ACCT OFFCR acquired 10,740 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 22,500 shares (grant or award)
Page 3 of 12 · 230 filings